Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
  Videos

Return

Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
SELECTBIO

We first report on a magnetic surface coverage assay, in which ‘large’ (2.8 μm) magnetic beads have contact with ‘small’ (1.0 μm) immobilized magnetic beads via magnetic dipolar interaction to induce specific immunocomplex formation. This attractive magnetic force is carefully balanced with a viscous drag imposed by a microfluidic flow to remove non-specifically bound large magnetic beads. In this way, a fg mL-1 limit of detection was demonstrated for Tumor Necrosis Factor-alpha (TNF-alpha) in serum, by counting of the number of surface-bound large beads. Subsequently, we report a microfluidic tissue processor that permits accurate quantification of the expression of biomarkers on tissue sections, as enabled by the ultra-rapid and uniform fluidic exchange of the device. An important clinical biomarker for invasive breast cancer is the human epidermal growth factor receptor 2 (HER2). Using our device, we performed tests on invasive breast carcinoma cases expressing various levels of HER2 and demonstrated the clinical potential of microfluidics for accurate biomarker expression analysis.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Monitoring Effectiveness Of Hay Fever Immunotherapy
A new test for measuring histamine release from certain white blood cells could help doctors monitor the effectiveness of immunotherapy for hay fever.
Developing a Noninvasive Test for Endometriosis
UCSF researchers identify patterns of genetic activity that could help in early detection of disorder.
Test Detects Early Brain Damage in Football Players
New Contrast-Enhanced MRI Developed by BGU Visualizes Brain Injury in the Blood-Brain Barrier Offering Significant Diagnostic Capabilities.
New Test Developed at Dana-Farber/Brigham and Women's Cancer Center
Rapid Heme Panel - A high-tech genetic test that speeds treatment decisions for blood cancer patients.
Urgent Need for Fast Dx to Help Tackle Antibiotic Resistance
£10 million Longitude Prize for an accurate, rapid, cost-effective and easy-to-use point-of-need diagnostic test for bacterial infections.
Test Developed To Rapidly Diagnose Bloodstream Infection
New technology can detect bacterial invaders with unprecedented speed and sensitivity.
Classification of Gene Mutations in Neuroblastoma
Penn Medicine and CHOP experts define riskier mutations in neuroblastoma, setting stage for clinical trial.
New Genetic Cause of Epilepsy Identified
San Diego girl improves after discovery of DNA mutation tied to potassium regulation.
Cancer Cell Fingerprints in the Blood May Speed up Childhood Cancer Diagnosis
Researchers found unique molecular fingerprints for 11 types of children’s tumours, to develop blood tests to diagnose these cancers.
Blood Test Developed to Diagnose Early Onset Alzheimer’s Disease
New blood-test could predict a person’s risk of developing AD much earlier than is currently possible.
Scroll Up
Scroll Down
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv